EN6-16036-17385
3 vaccinations
12 coded responses
29 check-ins
12 free-text entries
1 call case
- Sex
- —
- Age at first dose
- 36-40
- ZIP prefix
- 906 / CA
- Registered
- 2021-01-07
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-01-04
Dose 1 — Moderna
-
2021-01-07
Registered in v-safe
- 2021-01-07
-
2021-01-08
Survey response — days 1–6 daily, dose 1MedDRA: Chills — Feeling: Good · Site: Pain · ChillsFree text: I received the vsafe text yesterday and noticed daily check only asks about today. I had moderate chills on day 2 at night. Subsided the next morning.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-09
- 2021-01-11
- 2021-01-18
-
2021-01-25
Survey response — day 21, dose 1MedDRA: Headache — Feeling: GoodFree text: Off and on light headachesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-28
Dose 2 — Moderna
-
2021-02-08
Survey response — day 7, dose 2MedDRA: Chills, Fatigue, Myalgia, Pyrexia — Feeling: Good · Site: Pain · Chills, Headache, Muscle or body aches, Fatigue or tirednessFree text: Approximately 30 hours after i received 2nd dose i experienced chills, fatigue, muscled aches, and fever.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-11
-
2021-02-18
Survey response — day 21, dose 2MedDRA: Hypersensitivity, Oropharyngeal discomfort — Feeling: GoodFree text: Allergies and throat discomfort.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-25
- 2021-03-04
- 2021-03-11
-
2021-04-30
Survey response — 3 months, dose 2MedDRA: Rhinorrhoea — Feeling: GoodFree text: Sniffles. Not sure if due to weather (allergies). Subsided within 2 daysMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-07-31
Survey response — 6 months, dose 2MedDRA: Cough, Nasopharyngitis — Feeling: Poor · Be unable to work or attend schoolFree text: Cough and cold symptomsMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-10-29
Dose 3 — Moderna
- 2021-10-29
-
2021-10-30
Survey response — days 1–6 daily, dose 3MedDRA: Rhinorrhoea — Feeling: Good · Site: PainFree text: Slight runny noseMedDRA releases: 2024-11 · check-in free text available
-
2021-11-01
Survey response — days 1–6 daily, dose 3MedDRA: Unevaluable event — Feeling: Good · Site: Pain · Joint pains, Fatigue or tirednessFree text: Mostly on 10/30 eveningMedDRA releases: 2024-11 · check-in free text available
- 2021-11-02
- 2021-11-03
- 2021-11-04
- 2021-11-05
- 2021-11-12
-
2021-11-19
Survey response — day 21, dose 3MedDRA: Rhinorrhoea — Feeling: GoodFree text: Sniffles here and there. Could just be (b)(6) fluctuating weather and usual smog.MedDRA releases: 2024-11 · check-in free text available
- 2021-11-26
- 2021-12-03
- 2021-12-10
-
2022-01-28
Survey response — 3 months, dose 3MedDRA: Rhinorrhoea — Feeling: GoodFree text: Runny nose at times. Not sure if allergiesMedDRA releases: 2024-11 · check-in free text available
-
2022-05-01
Survey response — 6 months, dose 3MedDRA: Headache, Rhinorrhoea — Feeling: FairFree text: Mild runny nose, mild headachesMedDRA releases: 2024-11 · check-in free text available
-
2022-10-29
Survey response — 12 months, dose 3MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Got COVID19MedDRA releases: 2024-11 · check-in free text available
-
2022-10-29
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-11-01
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-04 | Moderna | |
| 2 | 2021-01-28 | Moderna | |
| 3 | 2021-10-29 | Moderna | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): I received the vsafe text yesterday and noticed daily check only asks about today. I had moderate chills on day 2 at night. Subsided the next morning.
Release 2 — day 21, dose 1
Symptoms: Off and on light headaches
Release 3 — day 7, dose 2
Systemic reaction (other): Approximately 30 hours after i received 2nd dose i experienced chills, fatigue, muscled aches, and fever.
Release 4 — day 21, dose 2
Symptoms: Allergies and throat discomfort.
Release 8 — 3 months, dose 2
Symptoms: Sniffles. Not sure if due to weather (allergies). Subsided within 2 days
Release 9 — 6 months, dose 2
Symptoms: Cough and cold symptoms
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Slight runny nose
Systemic reaction (other): Mostly on 10/30 evening
Release 10 — day 21, dose 3
Symptoms: Sniffles here and there. Could just be (b)(6) fluctuating weather and usual smog.
redacted (b)(6)
Release 11 — 3 months, dose 3
Symptoms: Runny nose at times. Not sure if allergies
Release 11 — 6 months, dose 3
Symptoms: Mild runny nose, mild headaches
Release 12 — 12 months, dose 3
Symptoms: Got COVID19
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | ✓ | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Hypersensitivity | ✓ | ✓ | ✓ |
| SD | Nasopharyngitis | ✓ | · | ✓ |
| SD | Oropharyngeal discomfort | ✓ | ✓ | ✓ |
| SD | Rhinorrhoea | ✓ | ✓ | ✓ |
| SRO | Chills | ✓ | ✓ | ✓ |
| SRO | Fatigue | ✓ | ✓ | ✓ |
| SRO | Myalgia | ✓ | ✓ | ✓ |
| SRO | Pyrexia | ✓ | ✓ | ✓ |
| SRO | Rhinorrhoea | · | · | ✓ |
| SRO | Unevaluable event | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release